2024 annual financial data

Enliven Therapeutics 2024 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -104.55M USD and net income was -89.02M USD.
Operating cash flow was -73.19M USD.

Get free Enliven Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-104.55M USD
Net income
-89.02M USD
Operating cash flow
-73.19M USD